Previous close | 0.2300 |
Open | 0.2000 |
Bid | 0.1500 |
Ask | 4.7000 |
Strike | 190.00 |
Expiry date | 2024-06-21 |
Day's range | 0.2000 - 0.2300 |
Contract range | N/A |
Volume | |
Open interest | 4 |
The Nasdaq hit a new high Tuesday but Target tumbled early Wednesday. Will Nvidia earnings tonight meet lofty hopes?
(Bloomberg) -- Hope for a weight-loss drug that’s better than Ozempic and Wegovy has sent Viking Therapeutics Inc. shares skyrocketing. But to reach the next level the biopharmaceutical developer likely needs a partner — or a buyer.Most Read from BloombergThese Flight Routes Suffer the World’s Worst TurbulenceOne Dead After Singapore Air Flight Hit By Severe Turbulence‘It Felt Like We Had Crashed’: Singapore Air Passenger Describes Turbulence TerrorBarclays Managers Warn Some Staff to Prepare fo
Eli Lilly is Tuesday's IBD Stock Of The Day after shares surged into a buy zone, again, on promising test results for a Crohn's treatment.